The pharmaceutical company of India, Aurobindo Pharma announced on Friday that its US-based joint venture firm – Cephazone Pharma LLC – has gained US approval for its anti-bacterial veterinary drug.

The Hyderabad-based drug manufacturer Aurobindo Pharma claimed that the US Food and Drug Administration Center for Veterinary Medicines has approved Cephazone Pharma’s Abbreviated New Animal Drug Application (ANDA) – “Ceftiofur Sodium Sterile Powder”.

The Ceftiofur Sodium Sterile Powder is the generic version of Pfizer's Naxcel. The drug is used for the treatment of several bacterial infections in animals including dogs, swine, horses and cattle.